济民药业,关爱无限 www.pidrug.com
香港济民药业微信二维码
198 9654 1773
当前位置:首页 > 药品资讯 > 精神科 > 多塞平doxepin

多塞平doxepin

[ 人气:145 | 日期: 2020-08-04 | 返回 | 打印 ]
多塞平doxepin
药品名称:多塞平doxepin
药品别名:多噻平凯舒 ,多虑平
英 文 名:doxepin
药品价格:$ 美国市场售价 24.28 美元
研发公司:
适 用 症:适用于各种抑郁症。各类焦虑抑郁状态,消化性溃疡。
型号规格:每粒含有效成份10mg/25mg/50mg/75mg/100mg,每瓶100粒装。
药品详情:

【多塞平doxepin 简述】
 
    本品又名多噻平凯舒 ,多虑平,是一种抗焦虑、抗抑郁药品。

多塞平doxepin_香港济民药业

多塞平doxepin_香港济民药业

 
多塞平doxepin_香港济民药业

多塞平doxepin_香港济民药业

多塞平doxepin_香港济民药业
 
【多塞平doxepin 适应症】
 
    具有抗焦虑、抗抑郁、镇静、催眠、肌肉松弛,抗消化性溃疡作用。适用于各种抑郁症。各类焦虑抑郁状态,消化性溃疡。
 
【多塞平doxepin 规格】
 
    本品为胶囊装,每粒含有效成份10mg/25mg/50mg/75mg/100mg,每瓶100粒装。
 
【多塞平doxepin 服用方法】
 
     口服成人常用量:开始一次 25mg,每日l—3次,然后逐惭增至每日150~300mg。
 
【多塞平doxepin 注意事项】
 
    有轻度嗜睡、口干、便秘等不良反应,一般较轻微。
 
【多塞平doxepin 不良反应】
 
    轻微,有口干、乏味、视物不清、便秘、尿潴留、头晕、心悸、低血压、恶心、呕吐、出汗、药疹、光敏感、瘙痒、局部水肿、性功能减退等。

 
Doxepin

 
    Doxepin is a medication used to treat major depressive disorder, anxiety disorders, chronic hives, and trouble sleeping.[8][9] For hives it is a less preferred option to antihistamines.[8] For sleeping problems it has a mild to moderate benefit.[10] As a cream it is used for itchiness due to atopic dermatitis or lichen simplex chronicus.[11]
 
    Common side effects include sleepiness, dry mouth, constipation, nausea, and blurry vision.[8] Serious side effects may include suicide in those under the age of 25, mania, and urinary retention.[8] A withdrawal syndrome may occur if the dose is rapidly decreased.[8] Use during pregnancy and breastfeeding is not generally recommended.[12][13] It is a tricyclic antidepressant (TCA).[8] While how it works for treating depression is unclear, it may involve increasing the levels of norepinephrine.[8] Although it also has antihistamine, anticholinergic, and antiserotonergic effects.[8]
 
    Doxepin was approved for medical use in the United States in 1969.[8] It is avaliable as a generic medication.[12] A month supply in the United Kingdom costs the NHS at least 100 £ as of 2019.[12] In the United States the wholesale cost of this amount is about 23 USD.[14] In 2016 it was the 239th most prescribed medication in the United States with more than 2 million prescriptions.[15]
 
Medical uses
 
    Doxepin is used as a pill to treat major depressive disorder, anxiety disorders, and chronic hives, and for short-term help with trouble remaining asleep after going to bed (a form of insomnia).[8][7][9] As a cream it is used for short term treatment of itchiness to due atopic dermatitis or lichen simplex chronicus.[11]
 
    In 2016 the American College of Physicians advised that insomnia be treated first by treating comorbid conditions, then with cognitive behavioral therapy and behavioral changes, and then with drugs; doxepin was among those recommended for short-term help maintaining sleep, on the basis of weak evidence.[16][17] The 2017 American Academy of Sleep Medicine recommendations focused on treatment with drugs were similar.[16] A 2015 AHRQ review of treatments for insomnia had similar findings.[18]
 
    A 2010 review found that topical doxepin is useful to treat itchiness.[19]
 
    A 2010 review of treatments for chronic hives found that doxepin had been superseded by better drugs but was still sometimes useful as a second-line treatment.[20]
 
 
Contraindications
 
    Known contraindications include:[21]
    Hypersensitivities to doxepin, other TCAs, or any of the excipients inside the product used
    Glaucoma
    A predisposition to developing urinary retention such as in benign prostatic hyperplasia
    Use of monoamine oxidase inhibitors in last 14 days[22]
 
Pregnancy and lactation
 
    Its use in pregnant and lactating women is advised against, although the available evidence suggests it is unlikely to cause negative effects on fetal development.[7] The lack of evidence from human studies, however, means it is currently impossible to rule out any risk to the fetus and it is known to cross the placenta.[7] Doxepin is secreted in breast milk[1] and neonatal cases of respiratory depression in association with maternal doxepin use have been reported.[23]
 
Overdose
 
    Like other TCAs, doxepin is highly toxic in cases of overdose.[25] Mild symptoms include drowsiness, stupor, blurred vision, and excessive dryness of mouth. More serious adverse effects include respiratory depression, hypotension, coma, convulsions, cardiac arrhythmia, and tachycardia. Urinary retention, decreased gastrointestinal motility (paralytic ileus), hyperthermia (or hypothermia), hypertension, dilated pupils, and hyperactive reflexes are other possible symptoms of doxepin overdose.[7] Management of overdose is mostly supportive and symptomatic, and can include the administration of a gastric lavage so as to reduce absorption of the doxepin.[7] Supportive measures to prevent respiratory aspiration is also advisable.[7] Antiarrhythmic agents may be an appropriate measure to treat cardiac arrhythmias resulting from doxepin overdose.[7] Slow intravenous administration of physostigmine may reverse some of the toxic effects of overdose such as anticholinergic effects.[7] Haemodialysis is not recommended due to the high degree of protein binding with doxepin.[7] ECG monitoring is recommended for several days after doxepin overdose due to the potential for cardiac conduction abnormalities.[7]
 



注:药品如有新包装,以新包装为准。以上资讯仅供医护人员内部讨论,不作任何用药依据,具体用药指引,请咨询主治医师。

更多相关资讯:返回顶部
最新药品资讯
  • Venclyxto(维奈妥拉)联合MabThera治疗慢淋白血病,患者死亡风险降低!
  • Tagrisso(Osimertinib)在英国获批用于两种肺癌适应症的治疗
  • ziritaxestat治疗弥漫性皮肤系统性硬化症(dcSSc)2期概念验证研究成功!
  • 美国FDA批准GSK三联疗法:可同时治疗哮喘和慢阻肺
  • NBIb-1817一次性治疗帕金森病(PD)显著改善运动功能、延长ON时间
  • 口服抗生素tebipenem HBr治疗cUTI和AP关键III期临床成功,疗效不劣于ertapenem
  • 下一代选择性免疫调节剂IMU-838治疗多发性硬化症(RRMS)具有显著疗效,有良好的安全性和耐受性!
  • Fintepla(芬氟拉明)口服溶液治疗Dravet综合征相关癫痫的第三项3期研究结果:抽搐发作显著减少
  • 视神经脊髓炎谱系障碍(NMOSD)创新药Enspryng(satralizumab)获美FDA批准
  • Fasenra与标准类固醇同时治疗鼻息肉三期临床结果积极
  • Darzalex Faspro申请新适应症,治疗轻链(AL)淀粉样变性!
  • 地诺单抗(Xgeva,denosumab)治疗实体瘤骨转移疗效怎样?
  • 新药IDH1抑制剂Tibsovo治疗胆管癌效果怎么样?
  • 拜耳Nubeqa(达罗他胺)治疗非转移性去势抵抗性前列腺癌显著延长患者生存!
  • FDA对罗氏Tecentriq治疗三阴性乳腺癌研究发出警告!
  • 加码多发性硬化症!罗氏启动三项临床试验研究
  • Xeglyze说明书-价格-功效与作用-副作用
  • 赛诺菲/再生元Dupixent(达必妥®)显著延缓哮喘患者肺功能下降:疗效维持3年!
  • 默沙东止咳药gefapixant2项关键III期临床试验成功:咳嗽频率显著降低
  • Ryplazim(纤溶酶原)再次申请上市:首个先天性纤溶酶原缺乏症(C-PLGD)治疗药物!
  • 拜耳Adempas用于经PDE5i治疗反应不足的肺动脉高压(PAH)患者IV期临床成功
  • Midostaurin(米哚妥林)适应症是什么?优势在哪里?
  • 艾普利Apixaban可以在哪里买到正品?
  • 维奈妥拉/维奈托克(VENETOCLAX)怎么服用?注意事项是什么?
  • 芦可替尼Ruxolitinib治疗特应性皮炎效果好不好?
  • 巯嘌呤片(6-MP)Puri-nethol治疗急性白血病效果如何?
  • 晚期HCC患者能从Ramucirumab中获益吗?
  • 赫赛汀+拉帕替尼治疗乳腺癌效果更好
  • 欧盟批准Imfinzi(英飞凡):一线治疗广泛期小细胞肺癌(ES-SCLC)!
  • 第三代强效COMT抑制剂Ongentys(opicapone)用于治疗帕金森病(PD)的新药在日本上市!


  • 如您发现本网站有文字编辑或内容错误,请点击此处发送(需要安装有foxmail或outlook支持),


    或发邮件至:info@morecare.hk,香港济民药业感谢您的到访!


    欢迎您添加香港济民药业微信,或在公众号内留言。

    香港济民微信公众号
    • 香港济民药业友情链接
    • 友情链接

    联系我们:

    地址:
    Rm. 314, Sun Ling Plaza, 30 On Kui Street, Fanling, HONG KONG
    邮箱:
    info@pidrug.com
    电话:
    198 9654 1773
    粤ICP备17150936号
    香港济民药业官方网站
    • 关注我们 :
    • 香港济民药业微博
    • 关注香港济民药业博客
    • 香港济民药业微信公众号